Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F47VK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,212
Award facts
- Contract value 100% obligated
- $38,211.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,211.84 delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pen injections, with a completion date of January 29, 2026. This competitively awarded, firm fixed-price delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The contract carries no set-aside designation, reflecting open competition in federal pharmaceutical procurement. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered.
This delivery order supports the Defense Health Agency and broader military healthcare systems' pharmaceutical supply needs. Dupixent is a biologic immunosuppressant used to treat moderate-to-severe atopic dermatitis, eczema, and other inflammatory conditions, making it part of the comprehensive pharmaceutical portfolio AmerisourceBergen maintains for federal medical institutions. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen leverages its prime IDC vehicle to efficiently fulfill government requirements for specialty medications, brand-name drugs, and medical supplies across multiple therapeutic domains supporting military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F47VK?
SPE2DR26F47VK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F47VK worth?
The government has obligated $38,212 on SPE2DR26F47VK.
Is contract SPE2DR26F47VK an order under another contract?
Yes. SPE2DR26F47VK is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47VK competed?
The extent of competition for SPE2DR26F47VK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award